Status
Conditions
Treatments
About
Extent of use of generics immunosuppressive drugs in clinical practice after lung transplantation
Full description
Solid organ transplant recipients are treated with immunosuppressive drugs to prevent rejection of their grafts. The most frequently important maintenance immunosuppressive drugs in Europe are calcineurin inhibitors.
For a number of these compounds drug patents have expired in recent years and generic formulations have entered the market. There is considerable debate regarding the efficacy and safety of generic drug substitution in solid organ recipients.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Imke Zinowsky; Jens Gottlieb, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal